Craig

W.

Hendrix

,

MD

Dr. Hendrix is the Wellcome Professor and Director, Division of Clinical Pharmacology at Johns Hopkins University in Baltimore. He received degrees in biology from MIT and medicine from Georgetown before residency training in internal medicine and post-doctoral fellowship training in infectious diseases and clinical pharmacology at Johns Hopkins. His 10 years on active duty in the Air Force includes assignments as Aerospace Physiologist at Andrews AFB, Director of the HIV Program at Wilford Hall Medical Center, and Senior Scientist in the Division of Retrovirology at Walter Reed Army Institute of Research. He served 3 years in the Air Force Reserve in the USAF Surgeon General’s office promoting global HIV prevention efforts with foreign militaries worldwide. In 1997, Dr. Hendrix joined the faculty at Johns Hopkins where he now holds appointments in Medicine, Pharmacology, and Epidemiology.

Dr. Hendrix’s primary research focus is the clinical pharmacology of drugs for HIV prevention, especially topical microbicides. This involves phase I to phase 3 clinical studies as method development studies designed to assess drug distribution systemically and at sites of HIV infection. As principal investigator or clinical pharmacologist, he has led 75 early phase clinical drug development studies, mostly related to antiretroviral drug development. He serves in several global HIV prevention trials networks as protocol pharmacologist in which he has paticipated in 65 multi-center clinical studies. He greatly enjoys teaching and mentoring trainees at all levels and co-leads the Hopkins Clinical Pharmacology T32 Training Program. He has also served on a National Academy of Medicine Advisory Panel, the CDC Board of Scientific Counselors, and several FDA Advisory Committees.